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Background: The long-term outcomes for drug-eluting (DES) and bare-metal stents (BMS) in ST-segment elevation myocardial infarction (STEMI) 
remains uncertain. In this meta-analysis we sought to determine the long-term outcomes for death, reinfarction, target vessel revascularization (TVR), 
and stent thrombosis for DES versus BMS in randomized trials.
Methods: We performed a literature review for relevant studies by searching Medline, conference proceedings, and the internet. We found 13 
randomized trials (n= 7,352 patients) that compared outcomes of patients with STEMI by stent type. Six studies (n=4,981 patients) reported 
outcomes ≥ 3 years from the index PCI. The effective size was measured as the relative risk (95% confidence interval) using random effects models.
Results: The outcomes for the safety endpoints (death, myocardial infarction, and stent thrombosis) and efficacy endpoint (TVR) are shown in the 
figure stratified by years from the index PCI.
Conclusions: The use of DES in patients with STEMI is associated with a durable long-term reduction in TVR without an increase in the safety 
endpoints of death, myocardial infarction, or stent thrombosis. 
